Drs. Akshay Thomas and Sarwar Zahid join to preview the May 2025 edition of Retinal Physician, focusing on future developments in stem cells, microbots, artificial intelligence, and more. Relevant Financial Disclosures: NoneBy Jayanth Sridhar

Drs. Avni Finn and Jordan Deaner join the program to share clinical pearls and thoughts from the 2025 Vit-Buckle Society Annual Meeting. Relevant Financial Disclosures: None You can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=AudiBy Jayanth Sridhar

Dr. Wu discusses prospective cognitive outcomes of children who had treatment for Retinopathy of Prematurity. The analysis suggests that cognitive outcomes were similar for children who had either laser or anti-VEGF injections for ROP treatment. Dr. Wu will be one of the invited guest speakers at the Canadian Retina Society meeting in Vancouver, BC…

Drs. Kovacs and Starr join for the latest gimmick the retina world is going wild for: how do you manage this retinal detachment scenario? Relevant Financial Disclosures: None You can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=AudiBy Jayanth Sridhar

Drs. Akshay Thomas and Priya Vakharia join to preview the April 2025 edition of Retinal Physician, focusing on current and future therapies for neovascular AMD. Relevant Financial Disclosures: Dr. Sridhar has consulted for Genentech, Regeneron, and Eyepoint. Dr. Vakharia has consulted for Regeneron, Ocular Therapeutix, and Eyepoint. You can claim C…

Dr. Pete Campbell of the Casey Eye Institute joins to discuss applications of artificial intelligence for screening of retinopathy of prematurity. Relevant Financial Disclosures: Dr. Campbell is co-founder and CEO of Siloam Vision, which is commercializing UWF-OCT, UWF-SLO and AI for ROP. You can claim CME credits for prior episodes via the AAO web…

Drs. Rebecca Soares, Akshay Thomas, and Sarwar Zahid join the podcast for a journal club discussion covering three recent articles in major ophthalmology journals. Macula-Off Retinal Detachment Prognostic Factors (https://journals.lww.com/retinajournal/abstract/9900/preoperative_and_early_postoperative_factors.944.aspx) Progression to PDR from NPDR…

This episode is a recording of the retina-focused EyeNovation webinar episode which was a collaboration between Canadian Ophthalmological Society and the Canadian Retina Society. Dr. Chakravarthy will provide a background to the double layer sign, its definition and how it is detected. Data to support the presentation will be from the EDNA trial . …

Drs. Katherine Talcott and Akshay Thomas join to discuss the March 2025 edition of Retinal Physician focusing on dry age-related macular degeneration, including photobiomodulation, complement inhibition, and deep learning for imaging. Relevant Financial Disclosures: Dr. Sridhar has consulted for Apellis. You can claim CME credits for prior episodes…

Drs. Akshay Thomas and Sarwar Zahid join the podcast to discuss 4 recent articles in major ophthalmology journals. GLP-1 Agonists (https://www.aaojournal.org/article/S0161-6420(25)00070-3/fulltext) Distribution of US Ophthalmologists (https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2828323) Representation Quotients in Ophthalmol…

Drs. Kruti Dajee, Andrew Hsia, and Nadeem Vaidya join the program to discuss solo retina practice in 2025. Disclosures: None relevant You can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=AudiBy Jayanth Sridhar

Dr. Jay Duker joins the program to discuss his transition from chair of an ophthalmology department to President & CEO of Eyepoint Pharmaceuticals. Disclosures: Dr. Duker is President & CEO of Eyepoint Pharmaceuticals. Dr. Sridhar has consulted for Eyepoint Pharmaceuticals. You can claim CME credits for prior episodes via the AAO website. Visit htt…

Dr. David Boyer joins the podcast to discuss the Lumithera Valeda (photobiomodulation) FDA approval and what it means for retina specialists and patients. Relevant Financial Disclosures: Dr. Boyer received research funding as a clinical trial site for Lumithera. You can claim CME credits for prior episodes via the AAO website. Visit https://www.aao…

Drs. Kat Talcott, Akshay Thomas, and Sarwar Zahid join the podcast for a journal club discussion covering three recent articles in major ophthalmology journals. Pneumatic Retinopexy IRIS Registry (https://www.ophthalmologyretina.org/article/S2468-6530(24)00526-8/fulltext) Macular Perfusion in Stable PDR (https://jamanetwork.com/journals/jamaophthal…

In this episode, Dr. Muni discusses two of his recent publications on repair of retinal detachment. In the first article, he discusses long-term reattachment rates of patients that were studied in the PIVOT trial, showing that both groups of patients who underwent either pneumatic retinopexy or vitrectomy had excellent long-term attachment rates. I…

Drs. Safa Rahmani and Sarwar Zahid join the podcast to preview the January 2025 edition of Retinal Physician, found online at http://www.retinalphysician.com. Relevant Financial Disclosures: Dr. Sridhar has consulted for Genentech and Regeneron. You can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multi…

Drs. Dolly Chang and Daniel Chao join the program to discuss the biggest differences in working in industry as an ophthalmologist versus normal clinical practice. Relevant Financial Disclosures: None You can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi…

Dr. NJ Manoharan joins the podcast to discuss working in a county hospital system as a retinal surgeon. Relevant Financial Disclosures: None You can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=AudiBy Jayanth Sridhar

Dr. Cindy Chen describes her group’s work on a retrospective review of association of systemic methotrexate therapy and a lower rate of proliferative vitreoretinopathy (PVR) after retinal detachment repair in large cohort of 2674 eligible patients.